InMed Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Revenue	4.83	4.6	4.14	1.09	-	-	Upgrade
Revenue Growth (YoY)	-11.94%	11.18%	279.61%	-	-	-	Upgrade
Cost of Revenue	3.12	3.5	2.73	0.55	-	-	Upgrade
Gross Profit	1.71	1.1	1.4	0.54	-	-	Upgrade
Selling, General & Admin	5.56	5.25	5.85	6.67	4.48	3.23	Upgrade
Research & Development	3.69	3.77	3.73	7.28	5.34	5.81	Upgrade
Operating Expenses	9.48	9.24	9.78	14.14	9.94	9.15	Upgrade
Operating Income	-7.77	-8.13	-8.38	-13.59	-9.94	-9.15	Upgrade
Interest & Investment Income	0.31	0.53	0.49	0.1	0.02	0.13	Upgrade
Currency Exchange Gain (Loss)	-0.1	-0.06	-0.05	-0.12	-0.16	0.08	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	-0.12	-	Upgrade
EBT Excluding Unusual Items	-7.91	-7.67	-7.93	-13.61	-10.2	-8.94	Upgrade
Merger & Restructuring Charges	-	-	-	-0.2	-	-	Upgrade
Impairment of Goodwill	-	-	-	-2.02	-	-	Upgrade
Asset Writedown	-	-	-	-1.45	-	-	Upgrade
Other Unusual Items	-	-	-	-1.31	-	-	Upgrade
Pretax Income	-7.91	-7.67	-7.93	-18.6	-10.2	-8.94	Upgrade
Income Tax Expense	0.01	0.01	0.01	-	-	-	Upgrade
Net Income	-7.91	-7.68	-7.95	-18.6	-10.2	-8.94	Upgrade
Net Income to Common	-7.91	-7.68	-7.95	-18.6	-10.2	-8.94	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	0	Upgrade
Shares Change (YoY)	154.47%	211.26%	336.59%	108.64%	28.72%	0.83%	Upgrade
EPS (Basic)	-13.88	-20.14	-64.92	-663.32	-759.16	-856.16	Upgrade
EPS (Diluted)	-13.88	-20.14	-64.92	-663.32	-759.16	-856.16	Upgrade
Free Cash Flow	-7.29	-7	-7.45	-15.62	-9.79	-7.42	Upgrade
Free Cash Flow Per Share	-12.79	-18.36	-60.81	-557.14	-728.60	-710.40	Upgrade
Gross Margin	35.39%	23.95%	33.93%	49.89%	-	-	Upgrade
Operating Margin	-160.71%	-176.92%	-202.60%	-1247.60%	-	-	Upgrade
Profit Margin	-163.77%	-166.94%	-192.18%	-1707.32%	-	-	Upgrade
Free Cash Flow Margin	-150.92%	-152.14%	-180.02%	-1434.03%	-	-	Upgrade
EBITDA	-7.55	-7.91	-8.18	-13.41	-9.82	-9.04	Upgrade
EBITDA Margin	-156.22%	-172.15%	-197.71%	-	-	-	Upgrade
D&A For EBITDA	0.22	0.22	0.2	0.19	0.12	0.11	Upgrade
EBIT	-7.77	-8.13	-8.38	-13.59	-9.94	-9.15	Upgrade
EBIT Margin	-160.71%	-176.92%	-202.60%	-	-	-	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q